NCT00543413 - A Study to Determine the Effectiveness and Tolerability of MK8141 in Patients With High Blood Pressure (MK-8141-006) | Biotech Hunter

Enrollment

160

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions

Hypertension

Interventions

DRUG

MK8141

MK8141 250 mg tablet once daily; 500 mg tablet once daily 4 week treatment period

DRUG

Comparator: placebo (unspecified)

MK8141 Pbo tablet once daily. 4 week treatment period.

DRUG

Enalapril

Enalapril 20 mg tablet once daily. 4 week treatment period.